<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">23070260</PMID>
<DateCompleted>
<Year>2013</Year>
<Month>08</Month>
<Day>01</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>12</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1434-4726</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>270</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2013</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery</Title>
<ISOAbbreviation>Eur Arch Otorhinolaryngol</ISOAbbreviation>
</Journal>
<ArticleTitle>Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis.</ArticleTitle>
<Pagination>
<MedlinePgn>641-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s00405-012-2221-2</ELocationID>
<Abstract>
<AbstractText>Recurrent respiratory papillomatosis (RRP) is a viral induced disease, associated with exophytic epithelial lesions affecting the upper airways. Problem of treatment is the high recurrence of papilloma growth after surgical removal; therefore adjuvant therapy schemes have been established. Cidofovir was one of the agents used off-label in adjuvant therapy in the last years. However, there is ongoing discussion about the effectiveness and possible side effects. Aim of our study was to share our experience in treatment of RRP with cidofovir during the last 11 years. We analyzed all the data of patients treated for RRP at the Department for Phoniatrics of the Medical University of Graz between 1999 and 2011. 25 out of the 34 treated patients are at the moment under complete remission, in six patients partial remission could be achieved and two patients showed poor response to therapy, therefore the treatment with cidofovir was stopped. 21 patients received one cycle of monthly cidofovir, 11 patients received two and one patient three cycles of therapy. Number of procedures reached from one to six during each cycle. Average cumulative dose of one cycle was 79.7 mg (15-277.5 mg), in one patient 435 mg were used. One patient developed temporary, borderline neutropenia without symptoms. Despite the retrospective approach of this study with the limitation of several incomplete records, our results show promising long-term effects of adjuvant use of cidofovir. During this period, we did not observe any relevant side effects.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Graupp</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Phoniatrics, ENT University Clinic, Speech and Swallowing, Medical University Graz, Auenbruggerplatz 26-28, 8036 Graz, Austria. matthias.graupp@gmx.at</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gugatschka</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kiesler</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Reckenzaun</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hammer</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Friedrich</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2012</Year>
<Month>10</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Germany</Country>
<MedlineTA>Eur Arch Otorhinolaryngol</MedlineTA>
<NlmUniqueID>9002937</NlmUniqueID>
<ISSNLinking>0937-4477</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D063065">Organophosphonates</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>8J337D1HZY</RegistryNumber>
<NameOfSubstance UI="D003596">Cytosine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>JIL713Q00N</RegistryNumber>
<NameOfSubstance UI="D000077404">Cidofovir</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C535297">Recurrent respiratory papillomatosis</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentIn">
<RefSource>Eur Arch Otorhinolaryngol. 2013 Jul;270(7):2165-6</RefSource>
<PMID Version="1">23545883</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="ErratumIn">
<RefSource>Eur Arch Otorhinolaryngol. 2013 Sep;270(10)2785</RefSource>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000998">Antiviral Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002648">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002675">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000077404">Cidofovir</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003596">Cytosine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000031">analogs &amp; derivatives</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007223">Infant</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D063065">Organophosphonates</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D030361">Papillomavirus Infections</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012008">Recurrence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012074">Remission Induction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012141">Respiratory Tract Infections</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2012</Year>
<Month>05</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2012</Year>
<Month>10</Month>
<Day>04</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2012</Year>
<Month>10</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2012</Year>
<Month>10</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2013</Year>
<Month>8</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">23070260</ArticleId>
<ArticleId IdType="doi">10.1007/s00405-012-2221-2</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Eur Arch Otorhinolaryngol. 2012 Feb;269(2):361-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22020697</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Otol Rhinol Laryngol. 2008 Jul;117(7):477-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18700421</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>HNO. 2005 Nov;53(11):921-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16142445</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Pediatr Otorhinolaryngol. 2006 Nov;70(11):1911-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16919339</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 1998 Mar;54(3):219-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9515772</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Otol Rhinol Laryngol. 2004 Nov;113(11):859-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15562893</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Arch Otorhinolaryngol. 2008 Aug;265(8):871-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18458927</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Otol Rhinol Laryngol. 2006 Jan;115(1):1-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16466093</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Laryngoscope. 1984 Jan;94(1):28-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6318005</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Opin Investig Drugs. 2002 Aug;11(8):1139-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12150707</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Pharmacokinet. 1999 Feb;36(2):127-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10092959</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Arch Otorhinolaryngol. 2008 Feb;265(2):147-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18046565</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Head Neck. 2007 Feb;29(2):155-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17022088</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Otolaryngol Head Neck Surg. 2007 Jun;136(6):863-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17547971</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Intern Med. 1997 Feb 15;126(4):257-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9036797</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2010 May 25;401(1):70-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20206957</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Otolaryngol Head Neck Surg. 2004 Sep;130(9):1039-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15381589</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Arch Otorhinolaryngol. 2011 Sep;268(9):1305-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21519834</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Laryngoscope. 2008 Jul;118(7):1236-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18496162</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Arch Otorhinolaryngol. 2006 May;263(5):440-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16328406</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Otolaryngol Head Neck Surg. 2008 May;134(5):497-500</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18490570</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Otolaryngol Head Neck Surg. 2002 Jun;126(6):642-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12087331</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>